Magnetic Hyperthermia Research Articles

A low-cost electronic and optical system for magnetic hyperthermia experimental studies

Magnetic hyperthermia is an alternative to treatments such as chemotherapy and radiotherapy that employs the heat generated by magnetic nanoparticles under the influence of a magnetic field to kill cancer cells while ideally causing no harm to healthy tissues. A low-cost magnetic hyperthermia investigation platform with commercially available and easy-to-assemble parts was presented to provide and expand research in this area for a larger scientific community. The magnetic hyperthermia measurement system consists of three main parts: a designed thermally insulated sample holder, a commercial 88 kHz magnetic induction heater, and a custom-built fiber optic based refractometer as temperature sensor. The system was tested with commercial EFH-1 magnetic fluids. Time dependent temperature changes were measured for applied magnetic fields of 3.5 kA/m, 4.8 kA/m, and 6.0 kA/m. The corresponding specific loss power values were calculated as 0.28 W/g, 0.51 W/g, and 0.79 W/g, respectively. Intrinsic loss power of commercial ferrofluid was determined as 0.25 ± 0.01 nHm2/kg, found to be comparable to the results of specialized commercial magnetic hyperthermia systems. The results show that the system can easily be used for hyperthermia demonstrations for educational purposes as well as in convenient scientific research with proper calibration.

Chronic whole-body heat treatment in obese insulin-resistant C57BL/6J mice

Aim This study examined the effects of hyperthermic therapy (HT) on mice fed normal chow or a high-fat diet (HFD) for 18 or 22 weeks, undergoing four or eight weekly HT sessions. Methods Mice were housed within their thermoneutral zone (TNZ) to simulate a physiological response. HFD-induced obesity-related changes, including weight gain, visceral fat accumulation, muscle loss (indicative of obesity sarcopenia), glucose intolerance, and hepatic triglyceride buildup. Main Results HT upregulated HSP70 expression in muscles, mitigated weight gain, normalised QUICK index, and reduced plasma HSP70 concentrations. It also lowered the H-index of HSP70 balance, indicating improved immunoinflammatory status, and decreased activated caspase-1 and proliferative senescence in adipose tissue, both linked to insulin resistance. Conclusion The findings suggest that even animals on a “control” diet but with insufficient physical activity and within their TNZ may experience impaired glycaemic homeostasis.

Investigation of the Application of Reduced Graphene Oxide-SPION Quantum Dots for Magnetic Hyperthermia.

Integrating hyperthermia with conventional cancer therapies shows promise in improving treatment efficacy while mitigating their side effects. Nanotechnology-based hyperthermia, particularly using superparamagnetic iron oxide nanoparticles (SPIONs), offers a simplified solution for cancer treatment. In this study, we developed composites of SPION quantum dots (Fe3O4) with reduced graphene oxide (Fe3O4/RGO) using the coprecipitation method and investigated their potential application in magnetic hyperthermia. The size of Fe3O4 nanoparticles was controlled within the quantum dot range (≤10 nm) by varying the synthesis parameters, including reaction time as well as the concentration of ammonia and graphene oxide, where their biocompatibility was further improved with the inclusion of polyethylene glycol (PEG). These nanocomposites exhibited low cytotoxic effects on healthy cells (CHO-K1) over an incubation period of 24 h, though the inclusion of PEG enhanced their biocompatibility for longer incubation periods over 48 h. The Fe3O4/RGO composites dispersed in acidic pH buffer (pH 4.66) exhibited considerable heating effects, with the solution temperature increasing by ~10 °C within 5 min of exposure to pulsed magnetic fields, as compared to their dispersions in phosphate buffer and aqueous dimethylsulfoxide solutions. These results demonstrated the feasibility of using quantum dot Fe3O4/RGO composites for magnetic hyperthermia-based therapy to treat cancer, with further studies required to systematically optimize their magnetic properties and evaluate their efficacy for in vitro and in vivo applications.

A Study on Overcoming Post-TACE Drug Resistance in HCC Based on Controllable Oxygen Release-Magnetic Hyperthermia Therapy.

Drug-eluting bead transcatheter arterial chemoembolization (D-TACE) is one of the first-line treatment for intermediate hepatocellular carcinoma (HCC). However, the dual hypoxia microenvironment, due to inherent tumor hypoxia and TACE-induced hypoxia, triggers drug resistance in HCC. To address this challenge, the study develops multicavitary microspheres capable of encapsulating oxygen and harnessing magnetic hyperthermia to enhance oxygen permeability. The novel multicavitary oxygen-encapsulated magnetothermal drug-eluting microspheres (OTD-Ms) effectively reduce hypoxia-related proteins (HIF-1α, VEGF-A) and drug resistance (P-gp) both in vitro and in vivo. Moreover, these microspheres demonstrate improved TACE efficacy and enhance survival rates in a rabbit VX-2 tumor model, suggesting their potential for HCC treatment.

Ferromagnetic-Antiferromagnetic Coupling in Gas-Phase Synthesized M(Fe, Co, and Ni)-Cr Nanoparticles for Next-Generation Magnetic Applications.

Combining ferromagnetic-antiferromagnetic materials in nanoalloys (i.e., nanoparticles, NPs, containing more than one element) can create a diverse landscape of potential electronic structures. As a result, a number of their magnetic properties can be manipulated, such as the exchange bias between NP core and shell, the Curie temperature of nanoparticulated samples, or their magnetocaloric effect. In this work, such a family of materials (namely M-Cr NPs where M is Fe, Co, Ni, or some combination of them) is reviewed with respect to the tunability of their magnetic properties via optimized doping with Cr up to its solubility limit. To this end, gas-phase synthesis has proven a most effective method, allowing excellent control over the physical structure, composition, and chemical ordering of fabricated NPs by appropriately selecting various deposition parameters. Recent advances in this field (both experimental and computational) are distilled to provide a better understanding of the underlying physical laws and point toward new directions for cutting-edge technological applications. For each property, a relevant potential application is associated, such as memory cells and recording heads, induced hyperthermia treatment, and magnetic cooling, respectively, aspiring to help connect the output of fundamental and applied research with current real-world challenges.

Evaluation of magnetic resonance thermometry performance during MR-guided hyperthermia treatment of soft-tissue sarcomas in the lower extremities and pelvis

Introduction This study evaluated the performance of magnetic resonance thermometry (MRT) during deep-regional hyperthermia (HT) in pelvic and lower-extremity soft-tissue sarcomas. Materials and methods 17 pelvic (45 treatments) and 16 lower-extremity (42 treatments) patients underwent standard regional HT and chemotherapy. Pairs of double-echo gradient-echo scans were acquired during the MR protocol 1.4 s apart. For each pair, precision was quantified using phase data from both echoes (‘dual-echo’) or only one (‘single-echo’) in- or excluding body fat pixels in the field drift correction region of interest. The precision of each method was compared to that of the MRT approach using a built-in clinical software tool (SigmaVision). Accuracy was assessed in three lower-extremity patients (six treatments) using interstitial temperature probes. The Jaccard coefficient quantified pretreatment motion; receiver operating characteristic analysis assessed its predictability for acceptable precision (<1 °C) during HT. Results Compared to the built-in dual-echo approach, single-echo thermometry improved the mean temporal precision from 1.32 ± 0.40 °C to 1.07 ± 0.34 °C (pelvis) and from 0.99 ± 0.28 °C to 0.76 ± 0.23 °C (lower extremities). With body fat-based field drift correction, single-echo mean accuracy improved from 1.4 °C to 1.0 °C. Pretreatment bulk motion provided excellent precision prediction with an area under the curve of 0.80–0.86 (pelvis) and 0.81–0.83 (lower extremities), compared to gastrointestinal air motion (0.52–0.58). Conclusion Single-echo MRT exhibited better precision than dual-echo MRT. Body fat-based field-drift correction significantly improved MRT accuracy. Pretreatment bulk motion showed improved prediction of acceptable MRT temporal precision over gastrointestinal air motion.

Magnetic Hyperthermia in Glioblastoma Multiforme Treatment.

Glioblastoma multiforme (GBM) represents one of the most critical oncological diseases in neurological practice, being considered highly aggressive with a dismal prognosis. At a worldwide level, new therapeutic methods are continuously being researched. Magnetic hyperthermia (MHT) has been investigated for more than 30 years as a solution used as a single therapy or combined with others for glioma tumor assessment in preclinical and clinical studies. It is based on magnetic nanoparticles (MNPs) that are injected into the tumor, and, under the effect of an external alternating magnetic field, they produce heat with temperatures higher than 42 °C, which determines cancer cell death. It is well known that iron oxide nanoparticles have received FDA approval for anemia treatment and to be used as contrast substances in the medical imagining domain. Today, energetic, efficient MNPs are developed that are especially dedicated to MHT treatments. In this review, the subject's importance will be emphasized by specifying the number of patients with cancer worldwide, presenting the main features of GBM, and detailing the physical theory accompanying the MHT treatment. Then, synthesis routes for thermally efficient MNP manufacturing, strategies adopted in practice for increasing MHT heat performance, and significant in vitro and in vivo studies are presented. This review paper also includes combined cancer therapies, the main reasons for using these approaches with MHT, and important clinical studies on human subjects found in the literature. This review ends by describing the most critical challenges associated with MHT and future perspectives. It is concluded that MHT can be successfully and regularly applied as a treatment for GBM if specific improvements are made.

3D-printed polycaprolactone-magnetic nanoparticles composite multifunctional scaffolds for bone tissue regeneration and hyperthermia treatment

Cancer management after tumor resection is characterized by two critical needs: (i) rehabilitation of the resected tissue and (ii) preventing post-surgical tumor recurrence by destroying any residual tumors. The state of the art in literature is limited because it tackles these two major priorities individually, it achieves tissue regeneration via autologous grafting and prevents tumor recurrence through chemotherapy. In this paper, extrusion 3D printing has been employed to manufacture composite multi-functional scaffolds with polycaprolactone (PCL) as a polymeric matrix and magnetic nanoparticles (MNPs) in a 0 to 50 wt% ratio, that would aid in bone regeneration and cancer management via magnetic hyperthermia treatment. The fabricated scaffolds were evaluated for their mechanical, magnetic and thermal characteristics. The Young&amp;rsquo;s modulus of the scaffolds increased multi-fold with increasing concentration of MNPs added to PCL (26.88&amp;plusmn;9.02 MPa for pure PCL to 229.06&amp;plusmn;37.05 MPa for PCL/50 wt% MNP scaffolds). PCL/MNP scaffolds displayed a directly proportional correlation between MNP concentration and saturation magnetization. While the in vitro tests showed a statistically significant cell growth of human Mesenchymal Stem Cells (hMSCs) over 7 days for all MNP concentrations, only the 50% MNP scaffold showed an increase in temperature over 41oC when subjected to an alternating magnetic field making it suitable for the hyperthermia treatment. On application of alternating magnetic fields to PCL and PCL/50 wt% MNP scaffolds, there was an increase in hMSCs proliferation and decrease in Bone cancer cells proliferation, thus proving the potential to be used as a multi-functional scaffold for post-surgical bone cancer management. &amp;nbsp;

Multi-Chambered Core/Shell Supraparticles for Real-Time, Full-Time Diagnosis and Treatment Integration of Tumors.

To a certain extent, theranostic nanoplatforms promote tumor treatment efficiency. However, timely monitoring of the critical stages and signal sustainability of the entire process is challenging. In this study, multi-chambered core/shell magnetic nanoparticles (MC-MNPs) as drug and imaging agent multi-loaded nanocarriers with a synergistic release function are reported. Supraparticles with stable chambers are formed by the supercooling self-assembly of several core/shell magnetic nanoparticles composed of amphiphilic copolymers as the core and hydrophilic magnetic iron oxide nanoparticles as the shell. Desalinized doxorubicin and coumarin 6 are stored in different cavities of nanocarriers, and chitosan is used as an outer encapsulation layer. Based on their construction properties, MC-MNPs can exhibit gradient-degraded and steady-released controllability in the tumor environment. Furthermore, real-time accumulation situations and full-time diagnostic signals of nanocarriers are thoroughly demonstrated using fluorescence imaging and T2-weighted magnetic resonance imaging before and after magnetic hyperthermia in targeted tumors under an alternating magnetic field. Thus, MC-MNPs as theranostic nanocarriers exhibit great potential for the timely monitoring and full-time guidance of tumor treatment.

Magnetic heating of interacting nanoparticles under different driving field waveforms

This study explores the impact of different magnetic driving field waveforms on nanoparticle heating in magnetic hyperthermia. Our research, which shifts the usual focus from individual nanoparticle properties to interacting particle clusters, evidences that square waves induce more uniform and greater heating than sinusoidal waves. The sequential switching observed with sinusoidal waves, which additionally strongly depends on the alignment of the particle cluster with respect to the direction of the field, leads to less uniform heating within and among different clusters. In contrast, a square waveform leads to simultaneous particle switching, thereby homogenizing the heat and potentially mitigating hazardous hot spots. These findings reaffirm the potential advantages for magnetic hyperthermia treatments using non-harmonic field waveforms, offering more uniform heating and the possibility of reducing the applied field exposure.

Design a metamaterial based applicator for hyperthermia cancer treatment

This research describes a metamaterial-based applicator with and without water bolus for cancer treatment. The metamaterial based applicator consists of a double spiral antenna and a slotted square shape artificial magnetic conductor (SSA) structure. The antenna is designed on a low-cost FR4 substrate with dimensions of 32 × 32 × 3.27 mm3, and the SSA unit cell which behaves as a metamaterial, is designed on an RT-duroid substrate with dimensions of 15 × 15 × 0.76 mm3 (size of the unit cell). The 4 × 4 unit cells of the SSA structure are optimized to direct the maximum field toward the cancer tissue. The proposed applicator (antenna + SSA structure) is tested for hyperthermia treatment using a heterogeneous phantom (skin, fat, and muscle layers) and the human-mimicked model with an air medium and a water bolus layer. The applicator’s performance is evaluated in terms of specific absorption rate (SAR), penetration depth (PD), and effective field size (EFS). Further, thermal analysis is performed, with 1.5 W of input power at the antenna port, and the maximum temperature rise of 44 0C is obtained. The cancer tissue (tumor) temperature ranges between 41 °C to 45 °C, sufficient for effective hyperthermia therapy. Finally, the suggested metamaterial based applicator is built and tested in the presence of a phantom and head tissue simulating liquid.

Evaluation of magnetic hyperthermia, drug delivery and biocompatibility (bone cell adhesion and zebrafish assays) of trace element co-doped hydroxyapatite combined with Mn-Zn ferrite for bone tissue applications.

The treatment and regeneration of bone defects, especially tumor-induced defects, is an issue in clinical practice and remains a major challenge for bone substitute material invention. In this research, a composite material of biomimetic bone-like apatite based on trace element co-doped apatite (Ca10-δ M δ (PO4)5.5(CO3)0.5(OH)2; M = trace elements of Mg, Fe, Zn, Mn, Cu, Ni, Mo, Sr and BO3 3-; THA)-integrated-biocompatible magnetic Mn-Zn ferrite ((Mn, Zn)Fe2O4 nanoparticles, BioMags) called THAiBioMags was prepared via a co-precipitation method. Its characteristics, i.e., physical properties, hyperthermia performance, ion/drug delivery, were investigated in vitro using osteoblasts (bone-forming cells) and in vivo using zebrafish. The synthesized THAiBioMags particles revealed superparamagnetic behaviour at room temperature. Under the influence of an alternating magnetic field, THAiBioMags particles demonstrated a change in temperature, indicating their potential for magnetic hyperthermia, in which THAiBioMags further exhibited a specific absorption rate (SAR) value of 9.44 W g-1 (I = 44 A, H = 6.03 kA m-1 and f = 130 kHz). In addition, the as-prepared particles demonstrated sustained ion/drug (doxorubicin (DOX)) release under physiological pH conditions. Biological assay analysis revealed that THAiBioMags exhibited no toxicity towards osteoblast cells and demonstrated excellent cell adhesion properties. In vivo studies employing an embryonic zebrafish model showed the non-toxic nature of the synthesized THAiBioMags particles, as revealed by evaluation of the survivability, hatching rate, and embryonic morphology. These results could potentially lead to the design and fabrication of magnetic scaffolds to be used in therapeutic treatment and bone regeneration.

Nanoengineered Injectable Hydrogel: An Advanced Radioprotective Barrier with Magnetic Hyperthermia Synergy.

Despite its effectiveness in eradicating cancer cells, current tumor radiotherapy often causes irreversible damage to the surrounding healthy tissues. To address this issue and enhance therapeutic outcomes, we developed a multifunctional injectable hydrogel that integrates electromagnetic shielding and magnetothermal effects. This innovation aims to improve the efficacy of brachytherapy while protecting adjacent normal tissues. Recognizing the limitations of existing hydrogel materials in terms of stretchability, durability, and single functionality, we engineered a composite hydrogel by self-assembling nickel nanoparticles on the surface of liquid metal particles and embedding them into an injectable hydrogel matrix. The resulting composite material demonstrates superior electromagnetic interference shielding performance (74.89 dB) and a rapid magnetothermal heating rate (10.9 °C/min), significantly enhancing its in vivo applicability. The experimental results confirm that this innovative nanocomposite hydrogel effectively attenuates electromagnetic waves during brachytherapy, thereby protecting normal tissues surrounding the tumor and enhancing radiotherapy efficacy through magnetothermal therapy. This study advances the safety and effectiveness of cancer treatments and provides new insights into the development of multifunctional biomedical materials, promoting the innovative application of nanotechnology in the medical field.

Multifrequency operation of an intracavitary monopole with sliding broadband choke for delivering hyperthermia treatment with variable coverage

ABSTRACT Microwave applicators reported for intracavitary hyperthermia (HT) operate at single frequency and deliver fixed treatment coverage at the tumor target. In this work, we report multifrequency operation of a water-cooled monopole antenna with a sliding broadband ferrite choke for delivering intracavitary HT to the cervix with variable spatial coverage. Spatially varying treatment coverage is achieved by varying the choke position with respect to the monopole using a mechanical sliding arrangement and exciting the antenna at the modified resonant frequency. Multifrequency operation of the antenna prototype is demonstrated over 700–1000 MHz using a straight intrauterine cervix applicator. Numerical simulations confirm the ability to deliver targeted HT with axial extent varying between 35.4 and 62.0 mm by controlling the sliding choke and coupling water temperature. Applicator prototype measurements in tissue mimicking phantoms confirm multifrequency operation of the antenna and its ability to induce axially varying intracavitary HT coverage to match the tumor size using a single applicator.

Photocatalytic degradation of rhodamine B using Yb3+-Doped Zn-Mg ferrites synthesized via conventional sol-gel auto-combustion method

The primary goal of our research is to develop a photocatalyst capable of degrading organic molecules in water, achieved through the rare earth Yb3+ doping of Zn-Mg spinel ferrites. A key element of our approach is the use of the conventional sol-gel auto-combustion process, which has proven to be an effective method for synthesizing a high-performing, visible light-driven Zn0.9Mg0.1Fe2-xYbxO4 (x = 0.000, 0.015, 0.030, 0.045, 0.060 and 0.075) nano-ferrites. Many analytical techniques were employed to evaluate the material's physicochemical characteristics, including P-XRD, EDX, FE-SEM, HR-TEM, FTIR, UV–vis, BET, VSM, EIS, and photocatalysis was carried out against the RhB. The impact of Yb3+ ion doping on the material's crystallite size and lattice parameter has been evaluated. It was found that all the samples' crystallite sizes increased between 33 and 41 nm. These magnetite nanoparticles have spherical forms and nanometric particle sizes, as revealed through field scanning electron microscopy (FE-SEM). The FTIR spectra bands at ʋ1 (518–535) and (401–411) ʋ2 subsequently revealed the spinel structure of the synthesized nano-ferrites. The band gap in zinc manganese ferrite increases from 2.51 eV to 2.92 eV after adding ytterbium. The surface area of the Yb3+-doped Zn-Mg ferries ranges from 23.6 m2/g to 27.8 m2/g, making them an excellent choice for data storage. The investigation of magnetic behavior shows the superparamagnetic behavior of all the samples. The produced sample's determined squareness value indicates the magnetostatic interaction between the particles. Because of the low produced coercive field value, these materials can be used in ferrofluids and hyperthermia therapy applications. Furthermore, with a higher RhB removal of 93.80 %, the Yb3+-doped sample photocatalyst successfully separated carriers generated by sunlight. The Yb3+-doped sample (ZMY-5) photocatalyst showed outstanding stability after one cycle of the stability test, obtaining an outstanding RhB elimination of 93.80 %. Zn0.9Mg0.1Yb0.075Fe1.925O4 photocatalyst has substantial promise for large-scale pollutant treatment due to its simple synthesis method, superior magnetic characteristics, exceptional photocatalytic activity for RhB, and excellent stability.

Thermomechanical interaction in a living tissue due to variable thermal loading with memory

AbstractIn order to address various clinical applications within living tissue, the aim of this work is to analytically study the thermomechanical interaction for a living tissue which is subjected to variable thermal loadings. Human tissues undergoing regional hyperthermia treatment for cancer therapy is based on graded changes of the cells, and as a consequences, the constitutive equations have been formulated using the nonlocal elasticity theory. The heat transport equation for the present problem is formulated in the context of Moore‐Gibson‐Thompson theory of generalized thermoelasticity assimilating the memory‐dependent derivative within a slipping interval. Both the boundaries of the tissue is maintaining the condition of zero traction. The lower boundary of the tissue is subjected to prescribed thermal loading while, the upper boundary is kept at zero temperature. Utilizing the Laplace transform mechanism, the governing equations have been solved and the general solutions have been obtained in the transformed domain. In order to arrive at the solutions in the real space‐time domain, suitable inversion of the Laplace transform has been carried out numerically using the method of Zakian. Numerical findings suggest that thermomechanical waves propagate through skin tissue over finite distances, which helps mitigate the unrealistic predictions made by the Pennes' model. Significant effect due to different effective parameter such as nonlocal parameter and the time‐delay parameter is reported. Also, how a nonlinear kernel function can be more effective in bio‐heat transfer, is outlined in the study also.

Magnetic-Nanorod-Mediated Nanowarming with Uniform and Rate-Regulated Heating.

Rewarming cryopreserved samples requires fast heating to avoid devitrification, a challenge previously attempted by magnetic nanoparticle-mediated hyperthermia. Here, we introduce Fe3O4@SiO2 nanorods as the heating elements to manipulate the heating profile to ensure safe rewarming and address the issue of uneven heating due to inhomogeneous particle distribution. The magnetic anisotropy of the nanorods allows their prealignment in the cryoprotective agent (CPA) during cooling and promotes subsequent rapid rewarming in an alternating magnetic field with the same orientation to prevent devitrification. More importantly, applying an orthogonal static magnetic field at a later stage could decelerate heating, effectively mitigating local overheating and reducing CPA toxicity. Furthermore, this orientational configuration offers more substantial heating deceleration in areas of initially higher heating rates, therefore reducing temperature variations across the sample. The efficacy of this method in regulating heating rate and improving rewarming uniformity has been validated using both gel and porcine artery models.

Nanostructural Modification of Fe2O3 Nanoparticles: Carbon Coating for Enhanced Magnetic Behavior

In this study, the enhancement of magnetic properties in Fe2O3 nanoparticles through nanostructural modification via carbon coating is investigated. Fe2O3 and carbon‐coated Fe2O3 nanoparticles are synthesized using the solvothermal method. Structural, morphological, optical, and magnetic properties are comprehensively analyzed. The results demonstrate a significant reduction in particle size upon carbon coating, effectively mitigating agglomeration. Furthermore, carbon‐coated nanoparticles exhibit substantial enhancement in coercivity, remanence, and saturation magnetization suggesting improved magnetic behavior in comparison to their uncoated counterparts. This enhancement is attributed to the prevention of spin misalignment at the nanoparticle surface by the carbon coating, as well as the formation of distinct magnetic domains due to the reduced particle size. The observed improvements underscore the effectiveness of carbon coating in tailoring the magnetic properties of Fe2O3 nanoparticles for applications in magnetic devices and biomedical systems, such as magnetic hyperthermia and drug delivery systems, where precise control over magnetic behavior is crucial.

Heating Up the Immune Battle: Magnetic Hyperthermia Against Cancer

Magnetic hyperthermia (MH) utilizes magnetic iron oxide nanomaterials (MIONs) to generate nano-scale heat and boost reactive oxygen species production within cells exposed to an external alternating magnetic field. Unlike conventional thermal ablation therapies that produce heat on a macro-scale, MIONs act as point source of heat inside cells, which enables MIONs-mediated MH to modulate cellular functions and fate with precision in real-time. With key benefits such as deep tissue penetration and the ability to regulate processes in a temporal-spatial and quantifiable manner, MH is now emerging as a new cancer therapy. Most intriguing is the apparent ability for MH to alter specific biological pathways associated with an anti-tumor immune response. Research efforts are now accelerating to render MH applicable to the clinical setting, with the objective of supporting the treatment of common cancers such as hepatocellular carcinoma (HCC). In this perspective paper, we highlight the recent progress made in MH, with a particular focus on its ability to manipulate anti-tumor immune mechanisms and the therapeutic advantages demonstrated thus far for HCC. We explore the current challenges in this field, and provide our perspective on the outlook for MH and its role in cancer treatment.

Green Capping Agents and Digestive Ripening for Size Control of Magnetite for Magnetic Fluid Hyperthermia

Background: Magnetite is the most recognized iron oxide candidate used for various biological applications. Objective: This work is a complete study that addresses the synthesis of magnetic nanoparticles and investigates the feasibility of using green tea and ascorbic acid as capping agents. Methods: Synthesis of magnetite by two wet chemical methods namely: coprecipitation and solvothermal methods. The samples were characterized using X-ray diffraction (XRD), transmission electron microscope (TEM), and vibrating sample magnetometer (VSM). Results: The results reveal the impact of coating on the size and morphology of the particles. The study also proves that autoclaving the samples prepared by coprecipitation results in smaller particle size and narrower size distribution due to digestive ripening. In addition, a novel and facile methodology for coating magnetite with polyethylene glycol is presented. The potential of the particles to be used for magnetic fluid hyperthermia is assessed by measuring the specific absorption rate (SAR) of the samples. Conclusión: The results show that all the prepared magnetite samples showed a promising capacity to be used as magnetic fluid hyperthermia agents.